reports
- GlobalData Healthcare Department
Xenon Pharmaceuticals Inc (XENE) - Financial Analysis Review
Xenon Pharmaceuticals Inc (XENE) - Financial Analysis Review Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc is a drug development company that discovers and develops of therapeutics for orphan indications. The company's pipeline products comprise Glybera, XEN801, sodium channel inhibitor and TV-45070. It discovers various validated drug targets through the study of rare human diseases with extreme traits, including channelopathies, diseases caused by mutations in ion ch...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.